Alvotech balance sheet ALVOW

Annual Quarterly

As of Dec 31, 2025, Alvotech had total assets of $1.5 billion and total liabilities of $1.8 billion. Total assets were up 21.8% from a year earlier. Stockholders' equity was negative, at -$284.5 million, because liabilities exceed assets. It held $172.4 million in cash and investments against $1.4 billion of total debt, net debt of $1.3 billion. The current ratio, current assets divided by current liabilities, was 1.89.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the year before.

FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
Assets
Cash
172
+235.1%
51
+360.9%
11
-83.2%
66
Cash and investments
172
+235.1%
51
+360.9%
11
-83.2%
66
Inventory
220
+72.1%
128
+71.8%
74
+4.1%
71
Total current assets
574
+26.2%
455
+133.5%
195
-15.6%
231
Property and equipment, net
356
+25.3%
285
+20.2%
237
+7.3%
221
Goodwill
13
+13.3%
11
-6.0%
12
+3.6%
12
Total assets
1,487
+21.8%
1,221
+28.6%
950
+14.7%
828
Liabilities and equity
Accounts payable
126
+87.9%
67
-16.7%
81
+63.8%
49
Total current liabilities
304
+57.2%
193
-25.9%
261
+56.0%
167
Total liabilities
1,772
+8.4%
1,634
-13.2%
1,883
+35.2%
1,393
Stockholders' equity
-284
+31.1%
-413
+55.7%
-932
-65.2%
-564
Debt
Debt due within a year
37
+12.9%
33
-14.0%
38
+90.9%
20
Long-term debt
1,262
+21.8%
1,036
+12.3%
922
+23.8%
745
Lease liabilities
150
+23.4%
122
+5.5%
115
+184.5%
41
Total debt
1,449
+21.8%
1,190
+10.7%
1,075
+33.6%
805
Net cash
-1,277
-12.1%
-1,139
-7.0%
-1,064
-44.1%
-739
Ratios
Current ratio
1.89x
2.35x
0.75x
1.38x
Return on assets
1.88%
-18.98%
-58.07%
-61.99%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ALVO (Nasdaq), ALVOW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Luxembourg
Headquarters
Luxembourg, Luxembourg
SEC filer status
Large accelerated filer
SEC CIK
1898416
Former names
Alvotech Lux Holdings S.A.S. (until May 2, 2022)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.